SCHEMBL7564008

SCHEMBL7564008

CCN(C(=O)c1c(O)c2c(Cl)c(C)ccc2[nH]c1=O)c1cccc(F)c1

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 2/20 0.40
RXFP1 Q9HBX9 2/20 0.40
TSHR P16473 1/20 0.40
ALDH1A1 P00352 2/20 0.38
LMNA P02545 2/20 0.38
HPGD P15428 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
MAPT P10636 2/20 0.38
NPC1 O15118 1/20 0.38
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
MAPK1 P28482 1/20 0.35
ATM Q13315 1/20 0.35
GPBAR1 Q8TDU6 1/20 0.35
NOS2 P35228 3/20 0.35
TP53 P04637 1/20 0.34
NOS3 P29474 1/20 0.34
NOS1 P29475 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL40302 0.88 MEN1 (0.45) NPSR1RXFP1TSHRALDH1A1SMN1; SMN2
SCHEMBL1830325 0.87 MEN1 (0.44) NPSR1RXFP1TSHRALDH1A1SMN1; SMN2
SCHEMBL5785897 0.87 MEN1 (0.44) NPSR1RXFP1TSHRALDH1A1SMN1; SMN2
SCHEMBL7826245 0.87 NPSR1 (0.39) NPSR1RXFP1TSHRALDH1A1LMNA
SCHEMBL7829858 0.80 MAPT (0.48) TSHRALDH1A1HPGDSMN1; SMN2MAPT
SCHEMBL7750180 0.80 MEN1 (0.45) NPSR1RXFP1TSHRALDH1A1LMNA
SCHEMBL2485564 0.77 MEN1 (0.45) NPSR1RXFP1TSHRALDH1A1HPGD
SCHEMBL7818937 0.76 PTGS2 (0.44) ALDH1A1HPGDSMN1; SMN2MAPTNPC1
SCHEMBL7556606 0.76 MEN1 (0.43) NPSR1RXFP1TSHRALDH1A1LMNA
SCHEMBL321543 0.76 MEN1 (0.45) NPSR1RXFP1TSHRALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1095021-A1 QUINOLINE DERIVATIVES Active Biotech AB (SE) 2001-05-02 EP claimed
WO-2000003991-A1 QUINOLINE DERIVATIVES ACTIVE BIOTECH AB (SE) 2000-01-27 WO claimed
EP-1224172-A1 DRUGS FOR THE TREATMENT OF MALIGNANT TUMOURS Active Biotech AB (SE) 2002-07-24 EP disclosed
WO-2001030758-A1 DRUGS FOR THE TREATMENT OF MALIGNANT TUMOURS ACTIVE BIOTECH AB (SE) 2001-05-03 WO disclosed
EP-1095021-A1 QUINOLINE DERIVATIVES Active Biotech AB (SE) 2001-05-02 EP disclosed
WO-2000003991-A1 QUINOLINE DERIVATIVES ACTIVE BIOTECH AB (SE) 2000-01-27 WO disclosed